Skip to main content
. 2022 Jul 25;227(1):9–17. doi: 10.1093/infdis/jiac317

Table 1.

Characteristics of m = 1888 Cases With Symptom Onset Between June 15, 2020 and September 30, 2021, Who Were Tested by RT-PCR at Least Once Between 3 Weeks Before Symptom Onset and 5 Weeks After Onset

Variable No. of Cases (m) % of Total Cases
Sex
 Female 932 49.4%
 Male 955 50.6%
 Unknown 1 0.1%
Age (years)
 0–19 550 29.1%
 20–39 765 40.5%
 40–59 459 24.3%
 60–79 109 5.8%
 ≥80 5 0.3%
Mean 31 (IQR, 17–44) 1888 100%
Status
 Confirmed 1887 99.9%
 Probable 1 0.1%
Overseas-Acquired
 Yes 610 32.3%
 No 1271 67.3%
 Unknown or NULL 7 0.4%
Time Period (Variant)
Symptom onset between June 15, 2020 and June 30, 2021 (original strain or earlier variants of concern) 670 35.5%
Symptom onset after July 1, 2021 (Delta variant) 1218 64.5%
Comorbidities
At least 1 266 14.1%
None 1622 85.9%
Vaccinated at Time of Diagnosis (at least 1 dose)
 Yes 242 12.8%
 Noa 1510 80.0%
 Unknown 136 7.2%
Ethnicity
Māori 225 11.9%
Pacific Peoples 844 44.7%
Non-Māori and non-Pacific (“Other”) 811 43.0%
Unknown 8 0.4%
Number of Tests
 1 1730 52.9%
 2 981 30.0%
 3 353 10.8%
 4 127 3.9%
 5 49 1.5%
 ≥6 32 1.0%
Days From Symptom Onset to First Test
 <−5 347 10.6%
 −5 69 2.1%
 −4 111 3.4%
 −3 127 3.9%
 −2 118 3.6%
 −1 178 5.4%
 0 314 9.6%
 1 322 9.8%
 2 325 9.9%
 3 268 8.2%
 4 215 6.6%
 5 164 5.0%
 6 144 4.4%
 7 111 3.4%
 8 109 3.3%
 9 74 2.3%
 ≥10 276 8.4%
Total 1888

Abbreviations: IQR, interquartile range; RT-PCR, reverse transcription polymerase chain reaction.

a

Includes unvaccinated cases with value “not applicable” in the immunized field, eg, those tested before vaccinations became available in New Zealand or individuals aged under 16 who were ineligible for vaccination.